September 7, 2023. Avelo, a Swiss breath diagnostics company with a mission to make every breath count for better infectious disease diagnosis, is one of the Top 10 Newcomers of the 2023 TOP 100 Swiss Startup Award.
For more info on the award and our ranking, click here.
About Avelo
Avelo AG, the Swiss breath aerosol diagnostic company, aims to revolutionize the diagnosis of Tuberculosis and lower respiratory tract infections causing pneumonia. Its breath collector enables non-invasive collection of pathogens from breath and works with existing PCR tests. The collector is designed for broad utility, similar to other sample collection technologies such as blood tubes. Avelo has a talented team experienced in business development, functional materials, product development, clinical research, and molecular diagnostics, and is based in Zurich-Schlieren.